Foster Dykema Cabot & Partners’s Amgen AMGN Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$152K	Hold	420	–	–	0.01%	132
2026 Q1	$148K	Hold	420	–	–	0.01%	130
2025 Q4	$137K	Sell	420 -347	-45%	-$110K	0.01%	142
2025 Q3	$216K	Buy	767 +347	+83%	+$101K	0.01%	131
2025 Q2	$117K	Hold	420	–	–	0.01%	155
2025 Q1	$131K	Hold	420	–	–	0.01%	142
2024 Q4	$109K	Sell	420 -334	-44%	-$99.1K	0.01%	166
2024 Q3	$243K	Buy	754 +190	+34%	+$62.2K	0.02%	113
2024 Q2	$176K	Sell	564 -48	-8%	-$14.1K	0.02%	106
2024 Q1	$174K	Buy	612 +45	+8%	+$13.2K	0.02%	109
2023 Q4	$163K	Buy	+567	New	+$154K	0.02%	102

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Foster Dykema Cabot & Partners's AMGN Position: Q2 2026 in Review

Foster Dykema Cabot & Partners held its Amgen (AMGN) position steady in Q2 2026 at 420 shares worth $152K. The position accounts for 0.01% of the portfolio, ranked #132.

Foster Dykema Cabot & Partners first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $243K in Q3 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Foster Dykema Cabot & Partners held 420 shares of Amgen worth $152K as of Q2 2026.
Foster Dykema Cabot & Partners left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.01% of Foster Dykema Cabot & Partners's portfolio in Q2 2026, its #132 holding.
Foster Dykema Cabot & Partners first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
Foster Dykema Cabot & Partners's Amgen position peaked at $243K in Q3 2024.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q2 2026, filed 11 Aug 2026.